A breakdown of the latest mutual funds holding Walgreens Boots Alliance Inc (WBA)

Stocks of Walgreens Boots Alliance Inc (NASDAQ:WBA) traded higher last session on Wall Street, up 0.83% to $10.89. WBA stock price is now 0.85% away from the 50-day moving average and 7.10% away from the 200-day moving average. The market capitalization of the company currently stands at $9.42B. With the price target reduced from $11 […]

Can Fidelity National Information Services, Inc (FIS) stock recover despite sales dropping?

In Thursday’s Wall Street session, Fidelity National Information Services, Inc (NYSE:FIS) shares traded at $74.58, up 8.65% from the previous session. FIS stock price is now 3.38% away from the 50-day moving average and -6.38% away from the 200-day moving average. The market capitalization of the company currently stands at $39.50B. With the price target […]

Gilead Sciences, Inc (GILD) – it’s time to buy. Check out key Indicators

Stocks of Gilead Sciences, Inc (NASDAQ:GILD) traded higher last session on Wall Street, down -0.32% to $104.54. GILD stock price is now -3.68% away from the 50-day moving average and 15.18% away from the 200-day moving average. The market capitalization of the company currently stands at $130.32B. With the price target enhanced from $115 to […]

Alight Inc (ALIT) Holding Strong: What’s pushing it?

The price of Alight Inc (NYSE:ALIT) shares last traded on Wall Street fell -0.80% to $4.99. ALIT stock price is now -18.13% away from the 50-day moving average and -27.87% away from the 200-day moving average. The market capitalization of the company currently stands at $2.71B. With the price target maintained at $8, JP Morgan […]

Abbott Laboratories (ABT) – Mismatched value: Check Out the Fundamental Analysis

In Thursday’s Wall Street session, Abbott Laboratories (NYSE:ABT) shares traded at $130.98, up 0.99% from the previous session. ABT stock price is now 0.15% away from the 50-day moving average and 10.95% away from the 200-day moving average. The market capitalization of the company currently stands at $227.16B. With the price target of $130, Oppenheimer […]